| 1 |
Guideline Brief report on the United States Food and Drug Administration Blood Products Advisory Committee recommendations for management of donors and units testing positive for hepatitis B virus DNA. 2006
Lucey C, Anonymous00018. · 21st Century Health Concepts, Ass., Houston, TX, USA. · Vox Sang. · Pubmed #17105609 No free full text.
Abstract: BACKGROUND AND OBJECTIVES: This article briefly recounts the 21st July 2005, Blood Products Advisory Committee (BPAC) meeting concerning recommendations for management of donors and units testing positive for hepatitis B virus (HBV) DNA. MATERIALS AND METHODS: The author attended the meeting. The United States Food and Drug Administration (FDA) web site was used for meeting materials, and handouts were collected at the meeting to provide narrative information. Two European experts assisted with HBV subject matter. RESULTS: The proceedings of the advisory committee, the issue briefing materials, and testing algorithms are presented. CONCLUSION: BPAC voted concurrence with the FDA algorithm for Management of Donors and Units Testing Positive for Hepatitis B Virus DNA.
|